Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.

Cleeland, Charles S; Sloan, Jeff A; Cella, David; Chen, Connie; Dueck, Amylou C; Janjan, Nora A; Liepa, Astra M; Mallick, Rajiv; O'Mara, Ann; Pearson, Jay D; Torigoe, Yasuhiro; Wang, Xin Shelley; Williams, Loretta A; Woodruff, Jeanie F

Cleeland, Charles S; Sloan, Jeff A; Cella, David; Chen, Connie; Dueck, Amylou C; Janjan, Nora A; Liepa, Astra M; Mallick, Rajiv; O'Mara, Ann; Pearson, Jay D; Torigoe, Yasuhiro; Wang, Xin Shelley; Williams, Loretta A; Woodruff, Jeanie F.

Affiliation

Cleeland CS; Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. ccleeland@mdanderson.org

Cancer ; 119(2): 411-20, 2013 Jan 15.

Article in En | MEDLINE | ID: mdl-22930243

Subject(s)

Clinical Trials as Topic/methods; Neoplasms/drug therapy; Outcome Assessment, Health Care/methods; Humans; Neoplasms/diagnosis; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Outcome Assessment, Health Care / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Guideline Aspects: Patient_preference Limits: Humans Language: En Journal: Cancer Year: 2013 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google